Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PIM1 | P11309 | 2/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.30 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2015390 | 0.85 | KMT2A (0.47) | KMT2ASMN1; SMN2MAPTALDH1A1L3MBTL1 | |
| SCHEMBL24942753 | 0.77 | KMT2A (0.55) | KMT2ASMN1; SMN2MAPTALDH1A1L3MBTL1 | |
| SCHEMBL1330434 | 0.69 | ACHE (0.33) | KMT2A | |
| SCHEMBL29142794 | 0.67 | KMT2A (0.40) | KMT2ASMN1; SMN2MAPTALDH1A1L3MBTL1 | |
| SCHEMBL2126173 | 0.67 | KMT2A (0.70) | KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL2142331 | 0.67 | KMT2A (0.70) | KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL2142335 | 0.67 | KMT2A (0.70) | KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL10008381 | 0.67 | KMT2A (0.70) | KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL31521404 | 0.67 | KMT2A (0.41) | KMT2ASMN1; SMN2MAPTALDH1A1L3MBTL1 | |
| SCHEMBL20555492 | 0.66 | KMT2A (0.35) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626423-A1 | CDK INHIBITORS AND METHODS AND USE THEREOF | Relay Therapeutics, Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| WO-2024119122-A1 | CDK INHIBITORS AND METHODS AND USE THEREOF | RELAY THERAPEUTICS, INC. (US) | 2024-06-06 | — | — | WO | disclosed |